Delivery Order SPE2DR25D1100-SPE2DR26FCS8K
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,987.14 to AmerisourceBergen Drug Corp for the supply of Veltassa 8.4 GM powder packets (30-count packages). This is a firm fixed price, competitively awarded contract with no set-aside designation, with a completion date of September 10, 2025. The award was issued on September 9, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,358.10 to AmerisourceBergen Drug Corp for the supply of Veltassa 8.4 GM powder packets (30-count) on May 30, 2025, with completion targeted for June 2, 2025. This firm fixed-price delivery order is non-set-aside and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $1,358.10 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Veltassa 8.4 gm powder packets (30-count units). This is a non-set-aside competitive award with an ultimate completion date of July 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count) valued at $3,964.51. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,471.39 for Veltassa 8.4 GM powder packets (30-count package) on December 8, 2025, with an ultimate completion date of December 9, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on September 10, 2025, for Veltassa 8.4 GM powder packets (30-count) with a ceiling value of $2,037.15 under firm fixed pricing. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 11, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $3,173.79 to AmerisourceBergen Drug Corp for Veltassa 8.4 GM powder packets (30-count). The contract, issued on July 10, 2025, with an ultimate completion date of July 11, 2025, utilizes firm fixed-price pricing under a non-set-aside competitive procurement. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a $2,565.83 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count units). This is a firm fixed-price contract with an ultimate completion date of August 26, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,431.22 to AmerisourceBergen Drug Corp for the supply of Veltassa 8.4 gm powder packets (30-count) on November 14, 2025, with completion targeted for November 17, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Veltassa 8.4 GM Powder Packet 30s on November 3, 2025, with a ceiling value of $1,984.07. This is a firm fixed price contract with an ultimate completion date of November 4, 2025. The award represents a non-competitive, non-set-aside delivery order placed under AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCS8KDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,443.60 to AmerisourceBergen Drug Corp for Veltassa 8.4 GM powder packets (30-count) on December 4, 2025, with ultimate completion scheduled for December 5, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for Defense Health Agency and military healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical supply requirements through competitive procurement processes, with delivery orders involving firm fixed pricing across varying transaction sizes. This specific award for Veltassa, a potassium-binding medication, supports the company's ongoing role as a primary supplier within the DLA's pharmaceutical supply chain for military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 12/3/25 |